ADAP
Adaptimmune Therapeutics plc
$0.18
-$0.00(-2.49%)
57
Overall
60
Value
58
Tech
55
Quality
Market Cap
$36.74M
Volume
36.73M
52W Range
$0.04 - $0.90
Target Price
$0.52
EPS Estimates Overview
| Current Quarter | $-0.09 | Next Quarter | $-0.07 |
| Current Year | $-0.48 | Next Year | $-0.21 |
| QoQ Growth | +22.2% | YoY Growth | +56.3% |
| 3Y EPS CAGR | +33.5% | Target Price | $0.52 |
| Consensus | Buy | Upside | +188.4% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ADAP | $0.18 | -2.5% | 36.73M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Adaptimmune Therapeutics plc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW